<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=510762&amp;fmt=gif">

Grace

Recent Posts

Why are you disqualifying your potentially great protein candidates

Injectability is a common screening criteria when determining the candidacy of protein therapeutics. Often times, the candidate protein therapeutics are scrutinized if the viscosity is higher than the pre-set threshold where the cut off viscosity ranges from 20 to 40 mPa-s depending on the delivery device. However, this type of generalization without specifying the shear rate could potentially lead to a false negative determination of an otherwise excellent therapeutic resulting in significant financial loss and time during development.

Evaporation Study

Recently, one of my customers brought up a concern that she had seen through other lab instrumentation during her experience in the lab. She asked how we deal with the particular evaporation effects of protein or other samples, especially when it comes to our VROC initium which handles 40 samples or up to 96 samples. So we put it to the test.

In VROC initium, technical information, application notes, Research

Technical Webinar - Guide to Formulation Development July 17, 2019 Wednesday 11:00 am PST

Formulation development is a complex process where meticulous attention to detail and the slightest variation could potentially impact the overall formulation or efficacy of the drug.

Attend webinar to access guide in formulation development

In VROC Technology, webinar, formulations, protein formulation, technical webinar, technical information